Details for New Drug Application (NDA): 202330
✉ Email this page to a colleague
NDA 202330 describes BUSPIRONE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Amneal Pharms Co, Aurobindo Pharma Ltd, Egis, Epic Pharma Llc, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Oxford Pharms, Rising, Rubicon Research, Strides Pharma, Teva, Unichem, and Zydus Pharms, and is included in twenty-one NDAs. It is available from forty-five suppliers. Additional details are available on the BUSPIRONE HYDROCHLORIDE profile page.
The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Summary for 202330
| Tradename: | BUSPIRONE HYDROCHLORIDE |
| Applicant: | Strides Pharma |
| Ingredient: | buspirone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202330
Suppliers and Packaging for NDA: 202330
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 202330 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8434 | 0615-8434-39 | 30 TABLET in 1 BLISTER PACK (0615-8434-39) |
| BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 202330 | ANDA | Strides Pharma Inc. | 42543-741 | 42543-741-06 | 100 TABLET in 1 BOTTLE (42543-741-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 25, 2014 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 25, 2014 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | Aug 25, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
